Search Results - "Kazuko Kamiyama"

Refine Results
  1. 1
  2. 2

    Dichloroacetate reduces cisplatin-induced apoptosis by inhibiting the JNK/14-3-3/Bax/caspase-9 pathway and suppressing caspase-8 activation via cFLIP in murine tubular cells by Kimura, Hideki, Kamiyama, Kazuko, Imamoto, Toru, Takeda, Izumi, Kobayashi, Mamiko, Takahashi, Naoki, Kasuno, Kenji, Sugaya, Takeshi, Iwano, Masayuki

    Published in Scientific reports (16-10-2024)
    “…Cisplatin-induced injury to renal proximal tubular cells stems from mitochondrial damage-induced apoptosis and inflammation. Dichloroacetate (DCA), a pyruvate…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells by Kobayashi, Mamiko, Mikami, Daisuke, Uwada, Junsuke, Yazawa, Takashi, Kamiyama, Kazuko, Kimura, Hideki, Taniguchi, Takanobu, Iwano, Masayuki

    Published in Oncotarget (31-07-2018)
    “…Short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate are generated by microbial fermentation of indigestible fiber by gut flora. SCFAs are…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line by Matsuta, Kohei, Kamiyama, Kazuko, Imamoto, Toru, Takeda, Izumi, Masunaga, Shinya, Kobayashi, Mamiko, Takahashi, Naoki, Kasuno, Kenji, Hara, Masanori, Iwano, Masayuki, Toyama, Tadashi, Kimura, Hideki

    Published in Cells (Basel, Switzerland) (28-08-2024)
    “…Peroxisome proliferator-activated receptor-alpha (PPAR-α) and its exogenous activators (fibrates) promote autophagy. However, whether the deleterious effects…”
    Get full text
    Journal Article
  9. 9

    Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells by Mikami, Daisuke, Kimura, Hideki, Kamiyama, Kazuko, Torii, Kunio, Kasuno, Kenji, Takahashi, Naoki, Yoshida, Haruyoshi, Iwano, Masayuki

    Published in Hypertension research (01-05-2014)
    “…Telmisartan, an angiotensin II receptor type 1 blocker (ARB), was recently reported to promote lipolysis in mice by acting as a peroxisome…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells by Kimura, Hideki, Li, Xuan, Torii, Kunio, Okada, Toshiharu, Kamiyama, Kazuko, Mikami, Daisuke, Kasuno, Kenji, Takahashi, Naoki, Yoshida, Haruyoshi

    Published in Clinical and experimental nephrology (01-02-2011)
    “…Background Glucocorticoid (GC) treatment reportedly exaggerates renal fibrosis in progressive kidney diseases during which hypoxia occurs as an unavoidable…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells by Kimura, Hideki, Mikami, Daisuke, Kamiyama, Kazuko, Sugimoto, Hidehiro, Kasuno, Kenji, Takahashi, Naoki, Yoshida, Haruyoshi, Iwano, Masayuki

    “…•TNF-α increased VEGF-C expression by enhancing phosphorylation of p38MAPK and HSP27.•Telmisartan decreased TNF-α-stimulated expression of VEGF-C.•Telmisartan…”
    Get full text
    Journal Article
  17. 17

    AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis HDAC inhibition by Daisuke Mikami, Mamiko Kobayashi, Junsuke Uwada, Takashi Yazawa, Kazuko Kamiyama, Kazuhisa Nishimori, Yudai Nishikawa, Sho Nishikawa, Seiji Yokoi, Takanobu Taniguchi, Masayuki Iwano

    Published in Therapeutic advances in medical oncology (01-03-2020)
    “…Background: Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide and establishment of new chemotherapies for HCC is urgently needed. GPR41…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20